In the present study, we showed that DUSP22 was significantly decreased in fatty liver of NASH individuals and in tumor tissues from NAFLD-HCC patients compared with the normal ones. The gene discussed is DUSP22; the disease is metabolic dysfunction-associated steatohepatitis.